| Specialty Retail Industry | Consumer Discretionary Sector | Ms. Lingzhong Kong CEO | XSHE Exchange | CNE100000NG5 ISIN |
| CN Country | 5,059 Employees | 21 May 2026 Last Dividend | 16 Jun 2014 Last Split | 16 Apr 2010 IPO Date |
Founded in 1995 and based in Guiyang, China, Guizhou Xinbang Pharmaceutical Co., Ltd. is a prominent entity in the research, development, manufacture, and sales of Chinese herbal medicines alongside other pharmaceutical products. Catering to both domestic and international markets, the company has established a significant presence in the pharmaceutical industry. It integrates traditional Chinese medicine with modern scientific approaches to provide effective healthcare solutions. Additionally, Guizhou Xinbang Pharmaceutical extends its services to include medical services, enhancing its role in the healthcare sector.
Cardiovascular and Cerebrovascular Medicines: These products are designed to target and treat conditions related to the heart and blood vessels, including stroke prevention and management. Utilizing the principles of Chinese herbal medicine, these treatments aim to improve blood circulation and overall cardiovascular health.
Digestive System Medicines: Dedicated to improving gastrointestinal health, these medicines address various digestive disorders. They are formulated to enhance digestion, alleviate discomfort, and promote a healthy digestive tract, aligning with traditional and modern therapeutic insights.
Endocrine System Medicines: Focusing on disorders related to hormone-secreting glands, these products aim to balance hormonal levels and treat conditions like diabetes and thyroid disorders. By leveraging the natural properties of herbal ingredients, they seek to restore endocrine system health.
Medical Services: Beyond its range of pharmaceutical products, Guizhou Xinbang Pharmaceutical also offers medical services. This includes consultations, treatment plans, and patient care services, reflecting the company’s holistic approach to healthcare and wellness.